Donor-Derived CD19 CAR T–Cell Therapy of Relapsed CD19-Positive B-ALL Following Allotransplant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Donor-Derived CD19 CAR-T Cell Therapy of Relapse of CD19-Positive B-ALL Post Allotransplant
Leukemia 2020 Oct 19;[EPub Ahead of Print], C Zhang, XQ Wang, RL Zhang, F Liu, Y Wang, ZL Yan, YP Song, T Yang, P Li, Z Wang, YY Ma, L Gao, Y Liu, L Gao, PY Kong, J Liu, X Tan, JF Zhong, YQ Chen, AB Liang, JH Ren, ZY Li, J Cao, QL Gao, J Zhou, Y Gao, D Zhang, FY Fan, MZ Han, RP Gale, X ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.